APPROACHING ALOPECIA TREATMENT VIA POLYMERIC NANOPARTICLES: A BRIEF OVERVIEW

Hair loss is a reality that plagues many people. One of the most common causes of hair loss today is androgenic alopecia, which is a progressive miniaturization of the follicle. After the COVID-19 pandemic, cases of alopecia had a sharp increase in the number of registered cases, indicating that an infection caused by the SARS-CoV-2 virus possibly stimulated a hair loss due to the stress caused by the infection, modified in the immune system and there were micro thrombi in the region of the hair follicle. There are some medicines in the markets that are well protected with drugs of international knowledge, such as minoxidil, finasteride and spirinolactone, which are already used for the treatment of alopecia. However, these drugs have difficulties in reaching the hair follicles, therefore, the delivery of drugs in polymeric nanoparticles demonstrated a promising strategy, with greater efficiency in the vectorization of these assets into the interior of the hair follicles, thus promoting greater efficiency. in the treatment of the pathology in question.